Immunology and Oncology

Immunology and Oncology at the Tübingen site

Cluster of Excellence iFIT- Image-Guided and Functionally Instructed Tumor Therapies

The Cluster of Excellence "Image-Guided and Functionally Instructed Tumor Therapies (iFIT)" aims to achieve a comprehensive understanding of biological processes in tumors in order to develop innovative and sustainable cancer therapies.

Learn more
German Consortium for Translational Cancer Research (DKTK)

In the German Consortium for Translational Cancer Research, researchers and doctors at eight locations in Germany are cooperating in order to bring promising approaches in cancer research into clinical practice more quickly.

Learn more

SFB/TR 156 - The skin as sensor and initiator of local and systemic immune reactions

The aim of the SFB is to understand skin immunity in its complexity in order to provide a basis for therapeutic interventions.

Learn more

SFB/TR 209 - Liver cancer

Liver cancer is the fifth most common tumor disease worldwide, with one of the highest mortality rates among all cancers. However, it is not yet known how liver cancer develops from the known risk factors - liver infection, liver cirrhosis or even metabolic diseases. The Collaborative Research Centre/Transregional Collaborative Research Centre "Liver cancer - new mechanistic and therapeutic concepts in a solid tumour model" aims to close these gaps in knowledge by combining basic research and clinical subprojects.

Learn more

FOR 2314: Solid tumours - Therapeutic Windows

The goal of the DFG Research Group FOR 2314 is to identify vital cellular processes in tumor cells in collaboration with researchers from the University of Würzburg, which can be used for an innovative therapy.

Learn more

FOR 2060: cGMP Signalling in Cell Growth and Survival

The unifying goal of the research group is to investigate how cGMP affects the remodeling, degeneration and regeneration of tissues in the cardiovascular, nervous and neurosensory systems.

Learn more about the SFB

Comprehensive Cancer CenterTübingen-Stuttgart - CCC

The German Cancer Aid supports the Southwest German Tumor Center at the University Hospital Tübingen.
In total, the German Cancer Aid supports 11 top oncological centers nationwide.

Learn more

in vivo analysis of cholangiocarcinoma development, progression and metastasis

Prof. Dr. Lars ZenderMedical
ITranslationalGastrointestinal Oncology

Learn more

Innovative cancer management: First in human senescence imaging

Prof. Dr. Bernd PichlerPreclinical
imaging and radiopharmacy

Learn more about

Peptide-based immunotherapy

The Department of Peptide-based Immunotherapy headed by Prof. Juliane Walz researches and develops T-cell-based immunotherapies for infectious and tumor diseases.

To the website